#Genomics surgery? #CRISPR and other DNA-editing technology may lead to future therapies. http://t.co/lBQt32jE1v pic.twitter.com/npYVDIFQBP
— Omicia Inc. (@Omicia) March 27, 2014
.@EricTopol Martin Reese of @Omicia:genomic analysis will switch from 80% research in 2013 to 80% clinical in 3-5 yrs pic.twitter.com/B8aksZe5zC
— CATHERINE COSTE (@cathcoste) April 1, 2014
http://mendelspod.com/podcast/bioinformatics-pioneer-martin-reese-scaling-human-genome-interpretation
Aucun commentaire:
Enregistrer un commentaire